The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial

BACKGROUND: Patients with major depression refractory to repeated pharmacological trials (TRD) may remain symptomatic for many years after their index episode. Augmentation strategies (with lithium or an atypical antipsychotic) or combining an antidepressant with short-term psychotherapy have been u...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaput, Yves, Magnan, Annick, Gendron, Alain
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553785/
https://www.ncbi.nlm.nih.gov/pubmed/18752690
http://dx.doi.org/10.1186/1471-244X-8-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553785/
https://www.ncbi.nlm.nih.gov/pubmed/18752690
http://dx.doi.org/10.1186/1471-244X-8-73

Ejemplares similares